-
Main Line Health is implementing temporary universal masking amid illnesses on the rise
Health experts say respiratory illnesses like COVID-19, the flu and RSV are on the rise and those numbers are going to continue to increase as people return from the holidays. It’s prompted Main Line Health to bring back universal masking at its facilities. temporarily NBC10’s Brian Sheehan has more.
-
CDC reporting rapid increase in respiratory illnesses following the holiday season
From COVID to the flu and RSV, infections are on the rise across the region. Health officials say travel and holiday gatherings are fueling the spike in respiratory illnesses. Hospitalizations are also on the rise and experts warn cases will continue to rise through the month of January. NBC10’s Rosemary Connors has more advice doctors are recommending to stay...
-
COVID, flu and RSV on the rise across the Philly region. Here's how to keep yourself safe
Health officials are warning that people in the Philadelphia region could be facing a “Tripledemic” this winter with COVID-19, the flu and RSV on the rise all at the same time .
-
Protect yourself from these 3 illnesses while traveling this holiday season
Those planning to travel or host parties over the holidays may want to take extra health precautions this year. Health experts say the “tripledemic” is back as many are getting sick from RSV, COVID, and the flu. NBC10’s Karen Hua explains how to keep yourself safe and minimize the spread of illness this holiday season.
-
Sicknesses are rising, Philadelphia Health Department recommends vaccinations to prevent illness
With the cold weather comes a season of sickness. With so many viruses spreading, such as the flu, COVID-19 and RSV, healthcare professionals are strongly suggesting getting vaccinated. NBC10’s Miguel Martinez-Valle has a message from the Philadelphia Health Department.
-
RSV vaccine from GSK shows potential to protect adults 50 to 59
The results suggest that GSK’s shot could help protect a wider population from RSV, which causes thousands of hospitalizations and deaths each year.
-
As RSV cases tick up, CDC warns that a key drug to keep babies safe is in short supply
The Centers for Disease Control and Prevention alerted doctors nationwide Monday about a limited availability of certain doses of a newly approved antibody drug given to infants to prevent RSV infection.
-
New RSV protections for infants hit cost, insurance hurdles in U.S. rollout
Pfizer’s maternal vaccine, Abrysvo, and Sanofi’s monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier this year.
-
CDC recommends Pfizer maternal RSV vaccine to protect infants, paving way for fall availability
The CDC specifically recommended that expectant mothers 32 to 36 weeks into their pregnancy receive the shot, Pfizer’s Abrysvo, from September through January.
-
CDC alerts doctors to an increase in RSV cases among young children and babies
The Centers for Disease Control and Prevention alerted doctors Tuesday about a rise in severe cases of RSV among young children in Florida and Georgia.
-
Sanofi expects infant RSV shot to roll out before respiratory virus season this fall
Sanofi said it is working with a CDC panel to include Beyfortus on the childhood immunization schedule and the Vaccines for Children Program.
-
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
-
Older Americans can get RSV vaccine this fall after consulting their doctor, CDC says
Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first.
-
FDA Advisers Back RSV Vaccine for Pregnant Women That Protects Their Newborns
A first-of-its-kind RSV vaccine for pregnant women guards their newborns against the scary respiratory virus -– and federal health advisers on Thursday backed Pfizer’s shot despite some lingering questions.
-
FDA Approves RSV Vaccines for Adults 60 and Up
The Food and Drug Administration has a approved the first RSV vaccine for adults 60 and older
-
Pfizer RSV Vaccine That Protects Infants Could Receive FDA Approval This Summer
The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.
-
Flu and RSV on the Decline But COVID Hospitalizations Rise
COVID-19 hospitalizations are rising in the United States, even as hospitalizations for respiratory syncytial virus and the flu continue to fall.
-
US to Release Medicine From National Stockpile as Flu Season Rages
The Biden administration says it will release doses of prescription flu medicine from the Strategic National Stockpile
-
Pharmacies Limit Sales of Kids' Medicines Amid Flu, RSV, COVID Wave: What Parents Can Do
Doctors and other experts say parents have alternatives if they encounter empty store shelves.
-
How Long Is THAT Contagious? Your Guide to Flu, Strep, COVID and Common Infections
Respiratory viruses, including COVID, flu and RSV, are spreading across the U.S. — and so are other infections. So how long are you contagious with some of the more common ones? Find out here.